Photodynamic therapy with fullerenes in vivo: reality or a dream?

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

References

• 1  Mroz P, Tegos GP, Gali H, Wharton T, Sarna T, Hamblin MR. Photodynamic therapy with fullerenes. Photochem. Photobiol. Sci.6(11),1139–1149 (2007).▪ First review of the use of fullerenes as photosensitizers in photodynamic therapy (PDT).
  Medline CASGoogle Scholar
• 2  Hamblin MR, Mroz P. Advances in Photodynamic Therapy: Basic, Translational and Clinical. Artech House, Norwood, MA, USA (2008).▪ Most recent and comprehensive textbook covering all aspects of PDT from chemistry, physics and biology to many different clinical applications of PDT for diverse diseases.
  Google Scholar
• 3  Agostinis P, Berg K, Cengel KA et al. Photodynamic therapy of cancer: an update. CA Cancer J. Clin.61(4),250–281 (2011).▪▪ Recent, comprehensive review of mechanisms and clinical application of PDT for cancer.
  MedlineGoogle Scholar
• 4  Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat. Rev. Cancer3(5),380–387 (2003).
  Medline CASGoogle Scholar
• 5  Dougherty TJ, Gomer CJ, Henderson BW et al. Photodynamic therapy. J. Natl Cancer Inst.90(12),889–905 (1998).
  Medline CASGoogle Scholar
• 6  Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem. Photobiol.55(1),145–157 (1992).
  Medline CASGoogle Scholar
• 7  Abels C. Targeting of the vascular system of solid tumours by photodynamic therapy (PDT). Photochem. Photobiol. Sci.3(8),765–771 (2004).
  Medline CASGoogle Scholar
• 8  Castano AP, Mroz P, Hamblin MR. Photodynamic therapy and anti-tumour immunity. Nat. Rev. Cancer6(7),535–545 (2006).▪ Discusses the particular ability of PDT of cancer to activate the immune system in addition to destroying the tumor and therefore potentially changing a local treatment into a systemic therapy.
  Medline CASGoogle Scholar
• 9  Hancock RE, Bell A. Antibiotic uptake into Gram-negative bacteria. Eur. J. Clin. Microbiol. Infect. Dis.7(6),713–720 (1988).
  Medline CASGoogle Scholar
• 10  Detty MR, Gibson SL, Wagner SJ. Current clinical and preclinical photosensitizers for use in photodynamic therapy. J. Med. Chem.47(16),3897–3915 (2004).
  Medline CASGoogle Scholar
• 11  Szeimies RM, Karrer S, Abels C et al. 9-Acetoxy-2,7,12,17-tetrakis-(beta-methoxyethyl)-porphycene (ATMPn), a novel photosensitizer for photodynamic therapy. uptake kinetics and intracellular localization. J. Photochem. Photobiol. B.34(1),67–72 (1996).
  Medline CASGoogle Scholar
• 12  Rosenthal I. Phthalocyanines as photodynamic sensitizers. Photochem. Photobiol.53(6),859–870 (1991).
  Medline CASGoogle Scholar
• 13  Agostinis P, Vantieghem A, Merlevede W, De Witte PA. Hypericin in cancer treatment: more light on the way. Int. J. Biochem. Cell Biol.34(3),221–241 (2002).
  Medline CASGoogle Scholar
• 14  Stockert JC, Juarranz A, Villanueva A, Canete M. Photodynamic damage to HeLa cell microtubules induced by thiazine dyes. Cancer Chemother. Pharmacol.39(1–2),167–169 (1996).
  Medline CASGoogle Scholar
• 15  Bottiroli G, Croce AC, Balzarini P et al. Enzyme-assisted cell photosensitization: a proposal for an efficient approach to tumor therapy and diagnosis. The rose bengal fluorogenic substrate. Photochem. Photobiol.66(3),374–383 (1997).
  Medline CASGoogle Scholar
• 16  Cataldo F, Da Ros T. Medicinal Chemistry and Pharmacological Potential of Fullerenes and Carbon Nanotubes. Springer Science+Business Media, NY, USA (2008).▪ Textbook covering a wide range of potential applications of fullerenes and carbon nanotubes in medicine, drug delivery and pharmaceutical science.
  Google Scholar
• 17  Duncan LK, Jinschek JR, Vikesland PJ. C60 colloid formation in aqueous systems: effects of preparation method on size, structure, and surface charge. Environ. Sci. Technol.42(1),173–178 (2008).
  Medline CASGoogle Scholar
• 18  Hotze EM, Labille J, Alvarez P, Wiesner MR. Mechanisms of photochemistry and reactive oxygen production by fullerene suspensions in water. Environ. Sci. Technol.42(11),4175–4180 (2008).
  Medline CASGoogle Scholar
• 19  Culotta L, Koshland DE Jr. Buckyballs: wide open playing field for chemists. Science254(5039),1706–1709 (1991).▪ One of the first suggestions that fullerenes had an important future role to play in biomedicine and what was later to become known as the field of nanomedicine.
  Medline CASGoogle Scholar
• 20  Oberdorster G. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J. Intern. Med.267(1),89–105 (2010).
  Medline CASGoogle Scholar
• 21  Gharbi N, Pressac M, Hadchouel M, Szwarc H, Wilson SR, Moussa F. [60]fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. Nano Lett.5(12),2578–2585 (2005).
  Medline CASGoogle Scholar
• 22  Kato S, Aoshima H, Saitoh Y, Miwa N. Biological safety of liposome-fullerene consisting of hydrogenated lecithin, glycine soja sterols, and fullerene-C60 upon photocytotoxicity and bacterial reverse mutagenicity. Toxicol. Ind. Health25(3),197–203 (2009).
  Medline CASGoogle Scholar
• 23  Kato S, Aoshima H, Saitoh Y, Miwa N. Fullerene-C60/liposome complex: defensive effects against UVA-induced damages in skin structure, nucleus and collagen type I/IV fibrils, and the permeability into human skin tissue. J. Photochem. Photobiol. B.98(1),99–105 (2009).
  MedlineGoogle Scholar
• 24  Doi Y, Ikeda A, Akiyama M et al. Intracellular uptake and photodynamic activity of water-soluble [60]- and [70]fullerenes incorporated in liposomes. Chemistry14(29),8892–8897 (2008).
  Medline CASGoogle Scholar
• 25  Yan A, Von Dem Bussche A, Kane AB, Hurt RH. Tocopheryl polyethylene glycol succinate as a safe, antioxidant surfactant for processing carbon nanotubes and fullerenes. Carbon N Y45(13),2463–2470 (2007).
  Medline CASGoogle Scholar
• 26  Akiyama M, Ikeda A, Shintani T et al. Solubilisation of [60]fullerenes using block copolymers and evaluation of their photodynamic activities. Org. Biomol. Chem.6(6),1015–1019 (2008).
  Medline CASGoogle Scholar
• 27  Kojima C, Toi Y, Harada A, Kono K. Aqueous solubilization of fullerenes using poly(amidoamine) dendrimers bearing cyclodextrin and poly(ethylene glycol). Bioconjug. Chem.19(11),2280–2284 (2008).
  Medline CASGoogle Scholar
• 28  Pan B, Cui D, Xu P et al. Synthesis and characterization of polyamidoamine dendrimer-coated multi-walled carbon nanotubes and their application in gene delivery systems. Nanotechnology20(12),125101 (2009).
  MedlineGoogle Scholar
• 29  Hooper JB, Bedrov D, Smith GD. Supramolecular self-organization in PEO-modified C60 fullerene/water solutions: influence of polymer molecular weight and nanoparticle concentration. Langmuir24(9),4550–4557 (2008).
  Medline CASGoogle Scholar
• 30  Nitta N, Seko A, Sonoda A et al. Is the use of fullerene in photodynamic therapy effective for atherosclerosis? Cardiovasc. Intervent. Radiol.31(2),359–366 (2008).
  MedlineGoogle Scholar
• 31  Liu J, Ohta S, Sonoda A et al. Preparation of PEG-conjugated fullerene containing Gd³⁺ ions for photodynamic therapy. J. Control. Release117(1),104–110 (2007).▪▪ Important study of PDT of a tumor in vivo with a fullerene derivatized to be both soluble and also to contain gadolinium ions that allow MRI and facilitate biodistribution studies.
  Medline CASGoogle Scholar
• 32  Tabata Y, Murakami Y, Ikada Y. Photodynamic effect of polyethylene glycol-modified fullerene on tumor. Jpn J. Cancer Res.88(11),1108–1116 (1997).▪ First report of the use of a functionalized fullerene to mediate PDT of a tumor in vivo.
  Medline CASGoogle Scholar
• 33  Filippone S, Heimann F, Rassat A. A highly water-soluble 2:1 beta-cyclodextrin-fullerene conjugate. Chem. Commun. (Camb.)14,1508–1509 (2002).
  Google Scholar
• 34  Zhao B, He YY, Bilski PJ, Chignell CF. Pristine (C60) and hydroxylated [C60(OH)24] fullerene phototoxicity towards HaCaT keratinocytes: type I vs type II mechanisms. Chem. Res. Toxicol.21(5),1056–1063 (2008).
  Medline CASGoogle Scholar
• 35  Bansal T, Mustafa G, Khan ZI, Ahmad FJ, Khar RK, Talegaonkar S. Solid self-nanoemulsifying delivery systems as a platform technology for formulation of poorly soluble drugs. Crit. Rev. Ther. Drug Carrier Syst.25(1),63–116 (2008).
  Medline CASGoogle Scholar
• 36  Shakeel F, Faisal MS. Nanoemulsion: a promising tool for solubility and dissolution enhancement of celecoxib. Pharm. Dev. Technol.15(1),53–56 (2009).
  Google Scholar
• 37  Bali V, Ali M, Ali J. Novel nanoemulsion for minimizing variations in bioavailability of ezetimibe. J. Drug Target18(7),506–519 (2010).
  Medline CASGoogle Scholar
• 38  Amani A, York P, Chrystyn H, Clark BJ. Factors affecting the stability of nanoemulsions – use of artificial neural networks. Pharm. Res.27(1),37–45 (2010).
  Medline CASGoogle Scholar
• 39  Boyd PD, Reed CA. Fullerene-porphyrin constructs. Acc. Chem. Res.38(4),235–242 (2005).
  Medline CASGoogle Scholar
• 40  El-Khouly ME, Araki Y, Ito O et al. Spectral, electrochemical, and photophysical studies of a magnesium porphyrin-fullerene dyad. Phys. Chem. Chem. Phys.7(17),3163–3171 (2005).
  Medline CASGoogle Scholar
• 41  Imahori H. Porphyrin-fullerene linked systems as artificial photosynthetic mimics. Org. Biomol. Chem.2(10),1425–1433 (2004).
  Medline CASGoogle Scholar
• 42  Schuster DI, Cheng P, Jarowski PD et al. Design, synthesis, and photophysical studies of a porphyrin-fullerene dyad with parachute topology; charge recombination in the marcus inverted region. J. Am. Chem. Soc.126(23),7257–7270 (2004).
  Medline CASGoogle Scholar
• 43  Vail SA, Schuster DI, Guldi DM et al. Energy and electron transfer in beta-alkynyl-linked porphyrin-[60]fullerene dyads. J. Phys. Chem. B.110(29),14155–14166 (2006).
  Medline CASGoogle Scholar
• 44  Gebhart SC, Lin WC, Mahadevan-Jansen A. In vitro determination of normal and neoplastic human brain tissue optical properties using inverse adding-doubling. Phys. Med. Biol.51(8),2011–2027 (2006).
  Medline CASGoogle Scholar
• 45  Tuchin VV, Wang RK, Yeh AT. Optical clearing of tissues and cells. J. Biomed. Opt.13(2),021101 (2008).
  MedlineGoogle Scholar
• 46  Hirshburg J, Choi B, Nelson JS, Yeh AT. Correlation between collagen solubility and skin optical clearing using sugars. Lasers Surg. Med.39(2),140–144 (2007).
  MedlineGoogle Scholar
• 47  Jiang J, Boese M, Turner P, Wang RK. Penetration kinetics of dimethyl sulphoxide and glycerol in dynamic optical clearing of porcine skin tissue in vitro studied by Fourier transform infrared spectroscopic imaging. J. Biomed. Opt.13(2),021105 (2008).
  MedlineGoogle Scholar
• 48  Kogan A, Garti N. Microemulsions as transdermal drug delivery vehicles. Adv. Colloid Interface Sci.123–126,369–385 (2006).
  Medline CASGoogle Scholar
• 49  Goeppert-Mayer M. Über elementarakte mit zwei Quantensprüngen. Ann. Phys.9,273–295 (1931).
  Google Scholar
• 50  Bhawalkar JD, Kumar ND, Zhao CF, Prasad PN. Two-photon photodynamic therapy. J. Clin. Laser Med. Surg.15(5),201–204 (1997).
  Medline CASGoogle Scholar
• 51  Karotki A, Khurana M, Lepock JR, Wilson BC. Simultaneous two-photon excitation of photofrin in relation to photodynamic therapy. Photochem. Photobiol.82(2),443–452 (2006).
  Medline CASGoogle Scholar
• 52  Samkoe KS, Clancy AA, Karotki A, Wilson BC, Cramb DT. Complete blood vessel occlusion in the chick chorioallantoic membrane using two-photon excitation photodynamic therapy: implications for treatment of wet age-related macular degeneration. J. Biomed. Opt.12(3),034025 (2007).
  MedlineGoogle Scholar
• 53  Samkoe KS, Cramb DT. Application of an ex ovo chicken chorioallantoic membrane model for two-photon excitation photodynamic therapy of age-related macular degeneration. J. Biomed. Opt.8(3),410–417 (2003).
  Medline CASGoogle Scholar
• 54  Arbogast JW, Darmanyan AP, Foote CS et al. Photophysical properties of C60. J. Phys. Chem. A. Mol. Spectrosc. Kinet. Environ. Gen. Theory95(1),11–12 (1991).
  CASGoogle Scholar
• 55  Foote CS. Photophysical and photochemical properties of fullerenes Top. Curr. Chem.169,347–363 (1994).
  CASGoogle Scholar
• 56  Yamakoshi Y, Umezawa N, Ryu A et al. Active oxygen species generated from photoexcited fullerene (C60) as potential medicines: O₂-* versus ¹O₂. J. Am. Chem. Soc.125(42),12803–12809 (2003).▪▪ Provides convincing evidence that fullerenes operate via a type I photochemical mechanism producing superoxide especially in aqueous biological environments.
  Medline CASGoogle Scholar
• 57  Koeppe R, Sariciftci NS. Photoinduced charge and energy transfer involving fullerene derivatives. Photochem. Photobiol. Sci.5(12),1122–1131 (2006).
  Medline CASGoogle Scholar
• 58  Guldi DM, Prato M. Excited-state properties of C(60) fullerene derivatives. Acc. Chem. Res.33(10),695–703 (2000).
  Medline CASGoogle Scholar
• 59  Arbogast JW, Foote CS, Kao M. Electron-transfer to triplet C-60. J. Am. Chem. Soc.114(6),2277–2279 (1992).
  CASGoogle Scholar
• 60  Lens M, Medenica L, Citernesi U. Antioxidative capacity of C(60) (buckminsterfullerene) and newly synthesized fulleropyrrolidine derivatives encapsulated in liposomes. Biotechnol. Appl. Biochem.51(Pt 3),135–140 (2008).
  Medline CASGoogle Scholar
• 61  Spohn P, Hirsch C, Hasler F, Bruinink A, Krug HF, Wick P. C60 fullerene: a powerful antioxidant or a damaging agent? The importance of an in-depth material characterization prior to toxicity assays. Environ. Pollut.157(4),1134–1139 (2009).
  Medline CASGoogle Scholar
• 62  Cai X, Jia H, Liu Z et al. Polyhydroxylated fullerene derivative C(60)(OH)(24) prevents mitochondrial dysfunction and oxidative damage in an MPP⁺-induced cellular model of Parkinson’s disease. J. Neurosci. Res.86(16),3622–3634 (2008).
  Medline CASGoogle Scholar
• 63  Dugan LL, Gabrielsen JK, Yu SP, Lin TS, Choi DW. Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol. Neurosci.3(2),129–135 (1996).
  CASGoogle Scholar
• 64  Andrievsky GV, Bruskov VI, Tykhomyrov AA, Gudkov SV. Peculiarities of the antioxidant and radioprotective effects of hydrated C60 fullerene nanostuctures in vitro and in vivo. Free Radic. Biol. Med.47(6),786–793 (2009).▪ Provides a possible explanation of the seeming paradox that on the one hand fullerenes can generate cytotoxic reactive oxygen species on illumination, and on the other hand, that fullerenes can quench reactive oxygen species and act as powerful antioxidants.
  Medline CASGoogle Scholar
• 65  Weiss DR, Raschke TM, Levitt M. How hydrophobic buckminsterfullerene affects surrounding water structure. J. Phys. Chem. B.112(10),2981–2990 (2008).
  Medline CASGoogle Scholar
• 66  Tokuyama H, Yamago S, Nakamura E. Photoinduced biochemical activity of fullerene carboxylic acid. J. Am. Chem. Soc.115,7918–7919 (1993).
  CASGoogle Scholar
• 67  Burlaka AP, Sidorik YP, Prylutska SV et al. Catalytic system of the reactive oxygen species on the C60 fullerene basis. Exp. Oncol.26(4),326–327 (2004).
  Medline CASGoogle Scholar
• 68  Rancan F, Rosan S, Boehm F et al. Cytotoxicity and photocytotoxicity of a dendritic C(60) mono-adduct and a malonic acid C(60) tris-adduct on Jurkat cells. J. Photochem. Photobiol. B.67(3),157–162 (2002).
  Medline CASGoogle Scholar
• 69  Yang XL, Fan CH, Zhu HS. Photo-induced cytotoxicity of malonic acid [C(60)]fullerene derivatives and its mechanism. Toxicol. In Vitro16(1),41–46 (2002).
  Medline CASGoogle Scholar
• 70  Mroz P, Pawlak A, Satti M et al. Functionalized fullerenes mediate photodynamic killing of cancer cells: type I versus type II photochemical mechanism. Free Radic. Biol. Med.43(5),711–719 (2007).▪ Shows that functionalized fullerenes are efficient mediators of PDT killing of cancer cells via a type I photochemical mechanism.
  Medline CASGoogle Scholar
• 71  Chiang LY, Padmawar PA, Rogers-Haley JE et al. Synthesis and characterization of highly photoresponsive fullerenyl dyads with a close chromophore antenna-C(60) contact and effective photodynamic potential. J. Mater. Chem.20(25),5280–5293 (2010).
  Medline CASGoogle Scholar
• 72  Kasermann F, Kempf C. Photodynamic inactivation of enveloped viruses by buckminsterfullerene. Antiviral Res.34(1),65–70 (1997).
  Medline CASGoogle Scholar
• 73  Hirayama J, Abe H, Kamo N et al. Photoinactivation of vesicular stomatitis virus with fullerene conjugated with methoxy polyethylene glycol amine. Biol. Pharm. Bull.22(10),1106–1109 (1999).
  Medline CASGoogle Scholar
• 74  Lin CP, Lynch MC, Kochevar IE. Reactive oxidizing species produced near the plasma membrane induce apoptosis in bovine aorta endothelial cells. Exp. Cell Res.259(2),351–359 (2000).
  Medline CASGoogle Scholar
• 75  Lee I, Mackeyev Y, Cho M et al. Photochemical and antimicrobial properties of novel C60 derivatives in aqueous systems. Environ. Sci. Technol.43(17),6604–6610 (2009).
  Medline CASGoogle Scholar
• 76  Tegos GP, Demidova TN, Arcila-Lopez D et al. Cationic fullerenes are effective and selective antimicrobial photosensitizers. Chem. Biol.12(10),1127–1135 (2005).▪ First demonstration that photoactivated cationic functionalized fullerenes are highly active, selective, broad-spectrum antimicrobials.
  Medline CASGoogle Scholar
• 77  Spesia MB, Milanesio ME, Durantini EN. Synthesis, properties and photodynamic inactivation of Escherichia coli by novel cationic fullerene C60 derivatives. Eur. J. Med. Chem.43(4),853–861 (2008).
  Medline CASGoogle Scholar
• 78  Huang L, Terakawa M, Zhiyentayev T et al. Innovative cationic fullerenes as broad-spectrum light-activated antimicrobials. Nanomedicine6(3),442–452 (2009).
  MedlineGoogle Scholar
• 79  Mizuno K, Zhiyentayev T, Huang L et al. Antimicrobial photodynamic therapy with functionalized fullerenes: quantitative structure-activity relationships. J. Nanomedic. Nanotechnol.2(2),100109–100117 (2011).
  Google Scholar
• 80  Isobe H, Tomita N, Nakamura E. One-step multiple addition of amine to [60]fullerene. synthesis of tetra(amino)fullerene epoxide under photochemical aerobic conditions. Org. Lett.2(23),3663–3665. (2000).
  Medline CASGoogle Scholar
• 81  Ikeda A, Doi Y, Nishiguchi K et al. Induction of cell death by photodynamic therapy with water-soluble lipid-membrane-incorporated [60]fullerene. Org. Biomol. Chem.5(8),1158–1160 (2007).
  Medline CASGoogle Scholar
• 82  Ikeda A, Matsumoto M, Akiyama M, Kikuchi J, Ogawa T, Takeya T. Direct and short-time uptake of [70]fullerene into the cell membrane using an exchange reaction from a [70]fullerene-gamma-cyclodextrin complex and the resulting photodynamic activity. Chem. Commun. (Camb.)12,1547–1549 (2009).
  Google Scholar
• 83  Ikeda A, Nagano M, Akiyama M et al. Photodynamic activity of C70 caged within surface-cross-linked liposomes. Chem. Asian J.4(1),199–205 (2009).
  Medline CASGoogle Scholar
• 84  Scrivens JMT, K.E. Creek, L Pirisi. Synthesis of C-14-labeled C-60, its suspension in water, and its uptake by human keratinocytes. J. Am. Chem. Soc.116,4517–4518. (1994).
  CASGoogle Scholar
• 85  Foley S, Crowley C, Smaihi M et al. Cellular localisation of a water-soluble fullerene derivative. Biochem. Biophys. Res. Commun.294(1),116–119 (2002).
  Medline CASGoogle Scholar
• 86  Porter AE, Gass M, Muller K, Skepper JN, Midgley P, Welland M. Visualizing the uptake of C60 to the cytoplasm and nucleus of human monocyte-derived macrophage cells using energy-filtered transmission electron microscopy and electron tomography. Environ. Sci. Technol.41(8),3012–3017 (2007).
  Medline CASGoogle Scholar
• 87  Levi N, Hantgan RR, Lively MO, Carroll DL, Prasad GL. C60-Fullerenes: detection of intracellular photoluminescence and lack of cytotoxic effects. J. Nanobiotechnol.4,14–25 (2006).
  MedlineGoogle Scholar
• 88  Tabata Y, Murakami Y, Ikada Y. Photodynamic effect of polyethylene glycol-modified fullerene on tumor. Jpn J. Cancer Res.88(11),1108–1116 (1997).
  Medline CASGoogle Scholar
• 89  Chi Y, Canteenwala T, Chen HC, Chen BJ, Canteenwala M, Chiang LY. Hexa(sulfobutyl)fullerene-induced photodynamic effect on tumors in vivo and toxicity study in rats. Proc. Electrochem. Soc.99,234–249 (1999).
  Google Scholar
• 90  Otake E, Sakuma S, Torii K et al. Effect and mechanism of a new photodynamic therapy with glycoconjugated fullerene. Photochem. Photobiol.86(6),1356–1363 (2010).
  Medline CASGoogle Scholar
• 91  Mroz P, Xia Y, Asanuma D et al. Intraperitoneal photodynamic therapy mediated by a fullerene in a mouse model of abdominal dissemination of colon adenocarcinoma. Nanomedicine doi:10.1016/j.nano.2011.04.007 (2011) (Epub ahead of print).▪ Shows that a photoactivated, functionalized fullerene was able to produce tumor response and increased survival in a new and challenging mouse model of disseminated metastatic cancer.
  MedlineGoogle Scholar
• 92  Lu Z, Dai T, Huang L et al. Photodynamic therapy with a cationic functionalized fullerene rescues mice from fatal wound infections. Nanomedicine (Lond.)5(10),1525–1533 (2010).▪▪ First study to show that PTD with a functionalized fullerene is able to save the life of mice at risk of dying from a highly aggressive and invasive bacterial infection.
  CASGoogle Scholar
• 93  Chen HH, Yu C, Ueng TH et al. Acute and subacute toxicity study of water-soluble polyalkylsulfonated C60 in rats. Toxicol. Pathol.26(1),143–151 (1998).
  Medline CASGoogle Scholar